PCS
TMO icon

Personal CFO Solutions’s Thermo Fisher Scientific TMO Stock Holding History

Personal CFO Solutions’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.15M Buy
2,329
+195
+9% +$106K 0.16% 111
2025
Q4 		$1.24M Buy
2,134
+107
+5% +$60.5K 0.2% 96
2025
Q3 		$983K Sell
2,027
-1,286
-39% -$599K 0.17% 117
2025
Q2 		$1.34M Sell
3,313
-62
-2% -$25.9K 0.25% 77
2025
Q1 		$1.68M Buy
3,375
+51
+2% +$27.6K 0.34% 54
2024
Q4 		$1.73M Sell
3,324
-129
-4% -$70.9K 0.34% 54
2024
Q3 		$2.14M Sell
3,453
-100
-3% -$59.2K 0.3% 66
2024
Q2 		$1.97M Buy
3,553
+114
+3% +$65.3K 0.3% 63
2024
Q1 		$2M Buy
3,439
+1,329
+63% +$746K 0.31% 63
2023
Q4 		$1.12M Buy
2,110
+43
+2% +$20.8K 0.19% 99
2023
Q3 		$1.05M Buy
2,067
+20
+1% +$10.7K 0.21% 97
2023
Q2 		$1.07M Buy
2,047
+34
+2% +$18.3K 0.22% 92
2023
Q1 		$1.16M Buy
2,013
+77
+4% +$43.4K 0.24% 81
2022
Q4 		$1.07M Buy
1,936
+1,134
+141% +$601K 0.23% 82
2022
Q3 		$407K Buy
802
+6
+0.8% +$3.36K 0.1% 190
2022
Q2 		$433K Buy
796
+14
+2% +$7.71K 0.1% 182
2022
Q1 		$462K Buy
782
+77
+11% +$44.2K 0.09% 213
2021
Q4 		$470K Buy
705
+92
+15% +$57.4K 0.09% 208
2021
Q3 		$350K Sell
613
-33
-5% -$18.1K 0.07% 251
2021
Q2 		$326K Buy
646
+109
+20% +$51.4K 0.07% 267
2021
Q1 		$245K Buy
537
+12
+2% +$5.73K 0.05% 323
2020
Q4 		$245K Buy
525
+52
+11% +$24.4K 0.06% 300
2020
Q3 		$0 Buy
+473
New +$195K ﹤0.01% 313

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Personal CFO Solutions's TMO Position: Q1 2026 in Review

Personal CFO Solutions increased its Thermo Fisher Scientific (TMO) stake by 9.1% in Q1 2026, buying an estimated $106K and bringing the position to 2,329 shares worth $1.15M. The position accounts for 0.16% of the portfolio, ranked #111.

Personal CFO Solutions first reported a position in TMO in Q3 2020 and has held it in 23 quarters since. The position peaked at $2.14M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Personal CFO Solutions held 2,329 shares of Thermo Fisher Scientific worth $1.15M as of Q1 2026.
  • Personal CFO Solutions bought 195 Thermo Fisher Scientific shares in Q1 2026, an estimated $106K.
  • Thermo Fisher Scientific made up 0.16% of Personal CFO Solutions's portfolio in Q1 2026, its #111 holding.
  • Personal CFO Solutions first reported a position in Thermo Fisher Scientific in Q3 2020 and has held it in 23 quarters since.
  • Personal CFO Solutions's Thermo Fisher Scientific position peaked at $2.14M in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Personal CFO Solutions's 13F filing for Q1 2026, filed 30 Apr 2026.